Genasys Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Genasys Inc. on July 10, 2024. The filing reports the appointment of a new member to the Board of Directors effective July 10, 2024.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The primary material change reported is the appointment of Mark Culhane to the Board of Directors. The Board determined that Mr. Culhane satisfies the "independent director" standards established by The Nasdaq Stock Market. He has been appointed to serve on both the Audit Committee and the Compensation Committee.
Compensation and Governance Details
- Term: Mr. Culhane's term continues until the 2025 Annual Meeting of Stockholders or until his successor is elected.
- Cash Compensation: Annual cash compensation of $30,000, paid quarterly.
- Equity Compensation: A pro-rated initial Restricted Stock Unit (RSU) grant of 20,000 shares of common stock based on the appointment date. Future annual grants are up to 30,000 shares, subject to an aggregate cap of $1,250,000 for independent directors.
- Indemnification: Mr. Culhane is expected to enter into the Company's standard form of indemnification agreement for non-employee directors.
Investor Verification Checklist
- Verify the independence status of Mark Culhane under Nasdaq rules.
- Confirm the pro-rated calculation of the initial 20,000 share RSU grant.
- Review the standard indemnification agreement referenced in the filing (Exhibit 10.1 from June 27, 2013).
- Check for any subsequent filings regarding the 2025 Annual Meeting of Stockholders.